ST Germain D J Co. Inc. Acquires New Stake in Docusign Inc. $DOCU

ST Germain D J Co. Inc. purchased a new position in Docusign Inc. (NASDAQ:DOCU) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 1,705 shares of the company’s stock, valued at approximately $133,000.

Several other large investors also recently added to or reduced their stakes in DOCU. Hemington Wealth Management increased its holdings in shares of Docusign by 318.1% in the first quarter. Hemington Wealth Management now owns 347 shares of the company’s stock worth $28,000 after buying an additional 264 shares during the period. Banque Transatlantique SA bought a new stake in Docusign during the 1st quarter valued at approximately $26,000. Golden State Wealth Management LLC boosted its position in Docusign by 519.4% during the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company’s stock valued at $31,000 after acquiring an additional 322 shares in the last quarter. Summit Securities Group LLC purchased a new position in shares of Docusign during the first quarter valued at approximately $34,000. Finally, MassMutual Private Wealth & Trust FSB lifted its holdings in shares of Docusign by 153.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 453 shares of the company’s stock valued at $37,000 after purchasing an additional 274 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.

Docusign Trading Up 0.3%

Shares of NASDAQ DOCU opened at $81.52 on Friday. The firm’s 50-day moving average price is $77.00 and its 200-day moving average price is $79.42. The stock has a market capitalization of $16.39 billion, a price-to-earnings ratio of 61.29, a P/E/G ratio of 4.27 and a beta of 1.02. Docusign Inc. has a 12-month low of $60.60 and a 12-month high of $107.86.

Docusign (NASDAQ:DOCU) last announced its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.08. The firm had revenue of $800.64 million for the quarter, compared to analysts’ expectations of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The business’s revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.97 EPS. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, equities analysts predict that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign declared that its Board of Directors has approved a share buyback program on Thursday, June 5th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 6.6% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its shares are undervalued.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on DOCU. Wells Fargo & Company lifted their target price on shares of Docusign from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Friday, September 5th. Royal Bank Of Canada boosted their target price on shares of Docusign from $90.00 to $95.00 and gave the company a “sector perform” rating in a research note on Friday, September 5th. Needham & Company LLC reiterated a “hold” rating on shares of Docusign in a research note on Friday, September 5th. JMP Securities reissued a “market outperform” rating and set a $124.00 price objective on shares of Docusign in a research report on Friday, September 5th. Finally, Wedbush dropped their target price on shares of Docusign from $100.00 to $85.00 and set a “neutral” rating for the company in a report on Thursday, June 12th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fourteen have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $94.14.

Insider Buying and Selling

In related news, Director Anna Marrs sold 728 shares of the stock in a transaction dated Monday, September 15th. The shares were sold at an average price of $80.30, for a total value of $58,458.40. Following the sale, the director directly owned 10,799 shares of the company’s stock, valued at $867,159.70. This represents a 6.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 9,509 shares of the stock in a transaction dated Wednesday, September 17th. The stock was sold at an average price of $83.10, for a total transaction of $790,197.90. Following the completion of the sale, the chief financial officer directly owned 112,160 shares in the company, valued at $9,320,496. This trade represents a 7.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 82,533 shares of company stock worth $6,598,028 over the last three months. 1.01% of the stock is currently owned by company insiders.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.